Formulation and Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Colchicine

Gout is one of the most prevalent rheumatic diseases, globally. Colchicine (COL) is the first-line drug used for the treatment of acute gout. However, the oral administration of COL is restricted, owing to serious adverse reactions. Therefore, this study aimed to develop a drug-in-adhesive (DIA) pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yaran, Yang, Guobao, Du, Feng, Yi, Jiahe, Quan, Liangzhu, Liu, Hanhan, Zhou, Xun, Gong, Wei, Han, Jing, Wang, Yuli, Gao, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611814/
https://www.ncbi.nlm.nih.gov/pubmed/36297680
http://dx.doi.org/10.3390/pharmaceutics14102245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611814/
https://www.ncbi.nlm.nih.gov/pubmed/36297680
http://dx.doi.org/10.3390/pharmaceutics14102245

Ejemplares similares